Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orabi (miconazole mucoadhesive tablets) to prevent oral candidiasis during radiotherapy for head and neck cancer
jRCTs071190023Completed
- Sponsor
- Nxera Pharma
- Start
- Apr 2020
- Countries
- 1
01
Overview
Open-label, single-arm trial in oral candidiasis and stomatitis, sponsored by Nxera Pharma. Primary endpoint: Development of oral candidiasis. Started Apr 2020; status: completed.
02
Conditions
oral candidiasisstomatitis
Beyond the preview
Go deeper on jRCTs071190023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071190023.